These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10048648)

  • 1. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
    Gniazdowska B; Ruëff F; Przybilla B
    Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic contact dermatitis to topical preparations of bufexamac.
    Pan Y; Nixon R
    Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
    Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
    Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
    [No Abstract]   [Full Text] [Related]  

  • 4. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
    Arikawa J; Okabe S; Kaneko T
    J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
    Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
    Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
    Nakada T; Matsuzawa Y
    Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
    Proske S; Uter W; Schnuch A; Hartschuh W
    Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
    Wong GN; Shen S; Nixon R
    Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
    Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
    Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contact allergies caused by bufexamac].
    Geier J; Fuchs T
    Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cutaneous sensitization to nonsteroidal anti-inflammatory drugs.
    Gonzalo MA; Revenga F
    Dermatology; 1996; 193(1):59-60. PubMed ID: 8864624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
    Koch P; Bahmer FA
    Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis to etofenamate. Cross-reaction to other nonsteroidal anti-inflammatory drugs.
    Alcántara Villar M; Pagan JA; Palacios L; Quiralte J; Ramirez M
    Contact Dermatitis; 2008 Feb; 58(2):118-9. PubMed ID: 18186756
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined contact and photocontact allergic dermatitis to etofenamate in flogoprofen gel.
    Sánchez-Pérez J; Sánchez TS; García-Díez A
    Am J Contact Dermat; 2001 Dec; 12(4):215-6. PubMed ID: 11753896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact and photocontact allergy to ketoprofen. The Belgian experience.
    Matthieu L; Meuleman L; Van Hecke E; Blondeel A; Dezfoulian B; Constandt L; Goossens A
    Contact Dermatitis; 2004 Apr; 50(4):238-41. PubMed ID: 15186381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives.
    Chu CY; Chen YL; Lin LJ; Sun CC
    Dermatology; 2003; 206(4):341-2. PubMed ID: 12771478
    [No Abstract]   [Full Text] [Related]  

  • 19. Contact allergy in chronic eczematous lip dermatitis.
    Schena D; Fantuzzi F; Girolomoni G
    Eur J Dermatol; 2008; 18(6):688-92. PubMed ID: 18955202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufexamac is a frequent contact sensitizer.
    Kränke B; Derhaschnig J; Komericki P; Aberer W
    Contact Dermatitis; 1996 Jan; 34(1):63-4. PubMed ID: 8789232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.